Atlas Trials

Dual Targeting of EGFR With Cetuximab and Afatinib to Treat Refractory wtKRAS Metastatic Colorectal Cancer

Clinical trial NCT01919879 · COMPLETED

Trial details

NCT number
NCT01919879
Sponsor
UNICANCER
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2012-10-01
Primary completion
2015-11-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.